As head of the Custom Intelligence team for the Americas and lead for cell and gene therapy thought leadership at Informa, Ly partners with clients to develop personalized solutions using Informa’s suite of pharma data and insights. She has 20+ years of experience in the healthcare and pharmaceutical industry and extensive experience in market research and analysis.
While at Informa, Ly has led research in therapy areas including oncology, autoimmune, and infectious diseases, offering expert opinion on strategy as well as disease, epidemiology, and drugs. Prior to her current role, she was Vice President of Disease Analysis and Strategy where she led a global analyst and market access team across the Datamonitor Healthcare and Biomedtracker solutions at Informa.
Ly has served as Commercial Strategy Director where she oversaw the content strategy and thought leadership team and as Director of Product and Service Development in the U.S., where she focused on developing content and building relationships with clients.
Ly first joined Informa in 2010 as an analyst for Datamonitor Healthcare, an Informa Pharma Intelligence product that specializes in in-depth market assessments and drug forecasts.
She has a PhD in Pharmacology from the University of New South Wales in Sydney, Australia and carried out her postdoctoral research with the Immunology team at Janssen, a Johnson & Johnson company.